May state legislative applications limit an Article V convention? Subject, yes; specific language, probably not
- September 12, 2013
FDA
- Home
- FDA
The FDA: killing promising adult stem cell research?0
- August 14, 2012
But instead of serving as our protector against charlatans who prey on the sick and desperate, the FDA has itself become an agent of coercion, forcibly denying us the freedom to use treatments that could save our lives. Continue reading
READ MOREThe Federal Governments War On Medical Innovation – Forbes0
- August 13, 2012
When you need advanced medical care in 2022, don’t let the government’s war on medical innovation restrict your doctor to today’s 2012 technology. Continue reading
READ MOREU.S. health care warning signs0
- April 5, 2012
Doctors struggling to make ends meet; ObamaCare at 2 years old: bad news;Commercial insurers have trouble staying in business;Drug companies are less ambitious; Super-high health plan premiums. Continue reading
READ MORE
The FDA vs. a doctor’s cancer cure & his patients0
- February 14, 2012
The FDA, which instigated four grand juries and two trials during its 12-year campaign to put Stanislaw Burzynski in prison, said it did not matter whether the Texas physician’s unconventional cancer treatments saved people’s lives. The point was that he had failed to get the FDA’s permission first. Continue reading
READ MOREThe FDA vs. a doctor’s cancer cure & his patients0
- February 14, 2012
The FDA, which instigated four grand juries and two trials during its 12-year campaign to put Stanislaw Burzynski in prison, said it did not matter whether the Texas physician’s unconventional cancer treatments saved people’s lives. The point was that he had failed to get the FDA’s permission first. Continue reading
READ MOREFDA & price controls kill by obstructing development of life-saving medications0
- September 9, 2011
“Over the past two years shortages have developed for over 180 drugs, including cancer treatments. [Why?] FDA regulation, government price controls on already discounted but complex drugs, and policies that discourage the use of new medications.” Continue reading
READ MORE
